Company intelligence / Profile preview

Synthego

Redwood City, California, United Statessynthego.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Synthego does not conduct its own clinical trials or have its own therapeutic pipeline. Instead, it supplies high-quality CRISPR reagents—including GMP-grade SpCas9 nuclease and sgRNAs—to academic labs and biopharma companies developing cell/gene therapies. Its products are used in preclinical through clinical-stage programs by customers worldwide.

Therapeutic areas: Other
Modalities: CRISPR-based therapyGuide RNA therapyGene editing tools
Industry: Non-Drug Biotech

Partnerships

Collaborates with commercial pharmaceutical/biotech companies and academic institutions

Beyond the preview

Go deeper on Synthego.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synthego.

Explore the full profile